The American Association for Cancer Research (AACR) 2018 Annual Meeting will be held from Saturday, April 14 to Wednesday, April 18 at McCormick Place North/South in Chicago, IL. Approximately 23,000 scientists will attend the meeting and discuss new advances in cancer research. For the full schedule of oral and poster presentations at which our physicians, scientists […]
Chicago Magazine has named the following 36 University of Chicago Medicine Comprehensive Cancer Center members to its Top Doctors list, which was published in the January issue. Neil H. Hyman Abraham H. Dachman Heber MacMahon Irving Waxman Ernst R. Lengyel S. Diane Yamada Richard A. Larson Wendy Stock Michael R. Bishop Suzanne D. Conzen Gini […]
Ernst Lengyel, MD, PhD, discusses the link between obesity and cancer.
The FDA approved a breakthrough cancer treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma, a form of non-Hodgkin lymphoma, that uses genetically engineered immune cells to target cancer.
With a $4.7 million grant from the National Cancer Institute, UChicago’s Globus and cancer researchers at UChicago Medicine will build new protected cancer research networks that enable collaborations while keeping sensitive health data secure and private.
Three UChicago researchers received awards from the NIH High-Risk, High-Reward Research program to support innovative approaches to tackle major challenges in biomedical research.
Lymphatic vessels, often blamed for enabling cancer cells to spread from a primary location to many other sites, have a flip side.
The University of Chicago Medicine is one of a limited number of U.S. sites working to offer a breakthrough gene therapy for pediatric acute lymphoblastic leukemia (ALL), which was just approved by the U.S. Food and Drug Administration.
A conversation with research specialist Larry House about his work and research experiences at UChicago.
A lifelong Notre Dame football fan’s journey as the first UChicago Medicine patient to receive a groundbreaking new cancer immunotherapy